Drug
Hydrocortisone hemisuccinate clinical trials
Also written Solu-Cortef and Hydrocortisone Sodium Succinate.
A product of Hydrocortisone; its studies count on that page too.
Keep track of what changes. Save the hydrocortisone hemisuccinate studies recruiting or about to start, and get an email each week — studies that open, close, add sites or post results.
Watch these studiesHow studies write it
Studies that test it under each name
Studies by the year they started
12 studies that test it; most in 2010 (2)
| Year | Studies |
|---|---|
| 2002 | 1 |
| 2007 | 1 |
| 2008 | 1 |
| 2010 | 2 |
| 2012 | 1 |
| 2014 | 1 |
| 2017 | 1 |
| 2020 | 1 |
| 2022 | 2 |
| 2023 | 1 |
By phase
A phase 1/2 study counts in both.
What it is tested for
Each study’s main condition, where its own words name it.
Who runs them
Industry 0 · Other 12
Haukeland University Hospital (2) · National Cancer Institute (NCI) (1) · Dana-Farber Cancer Institute (1) · Association Niçoise de Réanimation Médicale (1) · Rutgers, The State University of New Jersey (1) · Hadassah Medical Organization (1) · Kingman Regional Medical Center (1) · Beni-Suef University (1)
Often tested with
Tested in the same studies.
Dexamethasone (2) · Etoposide (2) · Clofarabine (1) · Dasatinib (1) · Daunorubicin (1) · Thioguanine (1) · Doxorubicin (1) · Cytarabine (1)
Related medicines
As reviewed, each with the page that says it.
- A salt or form of Hydrocortisone
Studies
Open first, then newest update. How each study uses hydrocortisone hemisuccinate is read from its arms, and is right about nine times in ten.
Testing it · 12
- Hemodynamic Response to Angiotensin-II When Used as the Second Vasopressor Agent for Septic ShockRecruitingPhase 4Kingman Regional Medical CenterNCT06122987Written as Angiotensin II and hydrocortisone sodium succinate
- Combination Chemotherapy in Treating Young Patients With Newly Diagnosed High-Risk B Acute Lymphoblastic Leukemia and Ph-Like TKI Sensitive MutationsCompletedPhase 3National Cancer Institute (NCI)NCT02883049Written as Hydrocortisone Sodium Succinate
- ALL Adult Consortium Trial: Adult ALL TrialCompletedPhase 2Dana-Farber Cancer InstituteNCT00476190Written as Hydrocortisone Sodium Succinate
- Ultradian Subcutaneous Hydrocortisone Infusion in Addison Disease and Congenital Adrenal HyperplasiaCompletedPhase 1/2Haukeland University HospitalNCT02096510Written as Solu-Cortef
- Corticosteroid Intralesional Injection as an Alternative Treatment in Oral Pyogenic Granuloma in the Esthetic Zone.Status unknownPhase 2/3Beni-Suef UniversityNCT05534334Written as Solu-Cortef
- The Effects of Two Brands of Hydrocortisone Injected Intramuscularly Into Deltoid and Thigh MusclesStatus unknownPhase 4The London ClinicNCT05350020Written as Solu-Cortef 100 MG Injection
- Low Dose Corticosteroid Infusion in Vasoplegia After Cardiac Surgery (CORTIVAS-CS)Status unknownPhase 3Instituto do CoracaoNCT04301479Written as hydrocortisone sodium succinate
- Mesalazine With Hydrocortisone Sodium Succinate Enema for 4-Week Treatment in Patients With Ulcerative ColitisStatus unknownPhase 4Xijing Hospital of Digestive DiseasesNCT03110198Written as hydrocortisone sodium succinate
- Hydrocortisone 50 mg Every 6 Hours Compared to Hydrocortisone 300 mg Per Day in Treatment of Septic Shock.CompletedPhase 4Association Niçoise de Réanimation MédicaleNCT02768740Written as Hydrocortisone hemisuccinate
- The Effects of Hydrocortisone in Endotoxemia in Normal VolunteersCompletedPhase 1Rutgers, The State University of New JerseyNCT01064986Written as Endotoxin, Lipopolysaccharide, LPS /Epinephrine
- Glucocorticoid Treatment in Addison's DiseaseCompletedPhase 2/3Haukeland University HospitalNCT01063569Written as Solu-Cortef (hydrocortisone)
- Corticosteroid Therapy of Septic Shock - CorticusCompletedPhase 3Hadassah Medical OrganizationNCT00147004Written as hydrocortisone sodium succinate
Given in every arm · 8 — hydrocortisone hemisuccinate is usual care beside what is tested
- A Study to Compare Blinatumomab Alone to Blinatumomab With Nivolumab in Patients Diagnosed With First Relapse B-Cell Acute Lymphoblastic Leukemia (B-ALL)RecruitingPhase 2National Cancer Institute (NCI)NCT04546399Written as Hydrocortisone Sodium Succinate
- A Study to Find the Highest Dose of Imetelstat in Combination With Fludarabine and Cytarabine for Patients With AML, MDS or JMML That Has Come Back or Does Not Respond to TherapyRecruitingPhase 1Children's Oncology GroupNCT06247787Written as Hydrocortisone Sodium Succinate
- Combination Chemotherapy With or Without Bortezomib in Treating Younger Patients With Newly Diagnosed T-Cell Acute Lymphoblastic Leukemia or Stage II-IV T-Cell Lymphoblastic LymphomaActive, not recruitingPhase 3National Cancer Institute (NCI)NCT02112916Written as Hydrocortisone Sodium Succinate
- A Study of Revumenib in Combination With Chemotherapy for Patients Diagnosed With Relapsed or Refractory LeukemiaActive, not recruitingPhase 2Children's Oncology GroupNCT05761171Written as Hydrocortisone Sodium Succinate
- Azacitidine and Combination Chemotherapy in Treating Infants With Acute Lymphoblastic Leukemia and KMT2A Gene RearrangementCompletedPhase 2National Cancer Institute (NCI)NCT02828358Written as Hydrocortisone Sodium Succinate
- A Study of the Drug IMGN632 in Children With Leukemia That Has Come Back After Treatment or is Difficult to TreatWithdrawnPhase 1/2Children's Oncology GroupNCT05320380Written as Hydrocortisone Sodium Succinate
- Dasatinib and Combination Chemotherapy in Treating Young Patients With Newly Diagnosed Acute Lymphoblastic LeukemiaCompletedPhase 2/3National Cancer Institute (NCI)NCT00720109Written as Hydrocortisone Sodium Succinate
- Rituximab, Rasburicase, and Combination Chemotherapy in Treating Young Patients With Newly Diagnosed Advanced B-Cell Leukemia or LymphomaCompletedPhase 2Children's Oncology GroupNCT00057811Written as hydrocortisone sodium succinate
As the comparator · 1 — what is tested is compared with hydrocortisone hemisuccinate
Codes
What other systems call hydrocortisone hemisuccinate · ClinicalTrials.gg INT002390
- MeSH (NLM) C007133hydrocortisone hemisuccinateConfirmed ClinicalTrials.gov, NLM, Wikidata
- UNII (FDA) LIU00Z1Z84HYDROCORTISONE HEMISUCCINATEConfirmed FDA, NLM, Wikidata
- Wikidata Q27283005hydrocortisone hemisuccinate hydrateConfirmed FDA, NLM, Wikidata
- NCI Thesaurus C61786Hydrocortisone HemisuccinateOne source FDA
| System | Code | Name there | Checked by |
|---|---|---|---|
| MeSH (NLM) | C007133 | hydrocortisone hemisuccinate | Confirmed ClinicalTrials.gov, NLM, Wikidata |
| UNII (FDA) | LIU00Z1Z84 | HYDROCORTISONE HEMISUCCINATE | Confirmed FDA, NLM, Wikidata |
| Wikidata | Q27283005 | hydrocortisone hemisuccinate hydrate | Confirmed FDA, NLM, Wikidata |
| NCI Thesaurus | C61786 | Hydrocortisone Hemisuccinate | One source FDA |
Also registered as hydrocortisone hemisuccinate anhydrous (UNII IHV1VP592V · RxNorm 21651) and hydrocortisone sodium succinate (UNII 50LQB69S1Z · RxNorm 235483).
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.